Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 7 min 23 sec ago

OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device

Wed, 04/02/2014 - 16:10
FRISCO, TX--(Healthcare Sales & Marketing Network) - OxySure Systems, Inc. (OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen ...
Devices, Regulatory
OxySure Systems, Emergency Oxygen Device

First Austrian cancer patients receive treatments on advanced Elekta Versa HD radiation therapy system

Wed, 04/02/2014 - 16:08
In complex cases, Medical University Innsbruck clinicians exploit speed and accuracy advantages of new groundbreaking linear accelerator INNSBRUCK, Austria, April 2, 2014 -- (Healthcare Sales & Marketing Network) -- Medical University Innsbruck is the ...
Devices, Oncology
Elekta, Versa HD, radiotherapy, radiosurgery

Leading Cancer Center in Italy Introduces Wider Range of Non-Surgical Cancer Treatments Using Varian's Edge(TM) Radiosurgery System

Wed, 04/02/2014 - 16:05
Clinicians at Humanitas Cancer Center in Milan among first in world to commence treatments using Edge radiosurgery system MILAN, Italy, April 2, 2014 -- (Healthcare Sales & Marketing Network) -- Humanitas Cancer Center in Milan has become one of the fi...
Devices, Oncology
Varian Medical Systems, Edge radiosurgery, radiosurgery, radiotherapy

Luoxis Obtains CE Marking for RedoxSYS(TM) Diagnostic System

Wed, 04/02/2014 - 16:02
Regulatory Clearance Enables Commercialization in Europe and other Key Markets GREENWOOD VILLAGE, Colo., April 2, 2014 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc., (NYSE MKT: AMPE) today announced that its subsidiary Luoxis...
Diagnostics, Regulatory
Ampio Pharmaceuticals, Luoxis, RedoxSYS

ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer

Wed, 04/02/2014 - 15:55
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--ARIAD Pharmaceuticals, Inc. (ARIA) today announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global busine...
Biopharmaceuticals, Oncology, Personnel
ARIAD Pharmaceuticals

Mazor Robotics to Launch and Demo New Renaissance(R) Brain Module at American Association of Neurological Surgeons (AANS) Annual Meeting in San Francisco

Wed, 04/02/2014 - 15:53
ORLANDO, Fla.--(Healthcare Sales & Marketing Network)--On April 7, 2014, Mazor Robotics (TASE:MZOR; NASDAQ GM:MZOR) will debut and officially launch the new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS...
Devices, Neurosurgery, Product Launch
Mazor Robotics, Renaissance Guidance System

EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals Inc.

Wed, 04/02/2014 - 15:49
WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company’s strong position as a late-stage, purpose-b...
Biopharmaceuticals, Neurology
EnVivo Pharmaceuticals, FORUM Pharmaceuticals, encenicline

Landmark Publication Affirms Safety of LINX(R), a New Treatment Option for Gastroesophageal Reflux Disease

Wed, 04/02/2014 - 13:00
ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Millions of Americans suffer from Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease that can cause debilitating symptoms and lead to serious complications including pre-can...
Devices, Gastroenterology
Torax Medical, GERD, Barrett’s esophagus, LINX procedure, LINX Reflux Management

Transcend Medical Announces Closing of $22 Million Series C Financing

Wed, 04/02/2014 - 12:47
Funding Supports Completion of Landmark Pivotal Trial for Breakthrough Glaucoma Micro-Stent MENLO PARK, CA--(Healthcare Sales & Marketing Network) - Transcend Medical, Inc., a medical device company dedicated to the development of minimally invasive gla...
Devices, Ophthalmology, Venture Capital
Transcend Medical, Glaucoma, CyPass, Micro-Stent

Ablative Solutions Receives FDA Clearance for the Peregrine System(TM) Infusion Catheter

Wed, 04/02/2014 - 12:40
KALAMAZOO, Mich., April 2, 2014 -- (Healthcare Sales & Marketing Network) -- Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Devices, FDA
Ablative Solutions, Peregrine System, Infusion Catheter

Immune CEO Announces New Operational Leadership Team

Wed, 04/02/2014 - 12:33
Elliott Goldstein, MD, Joins as Chief Medical Officer; Eugene Williams Joins as Chief Operating Officer NEW YORK and HERZLIYA, Israel, April 2, 2014 -- (Healthcare Sales & Marketing Network) -- Immune Pharmaceuticals Inc. (IMNP.ST) (IMNP.ST) announced t...
Biopharmaceuticals, Personnel
Immune Pharmaceuticals, bertilimumab

Aptus Endosystems Appoints Dr. Bart E. Muhs as Chief Medical Officer

Tue, 04/01/2014 - 15:56
SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)--Aptus Endosystems, Inc., a medical device company pioneering solutions to enhance aneurysm repair, today announced that it has appointed Bart Edward Muhs, M.D., Ph.D. to the position of Chief Medic...
Devices, Cardiology, Surgery, Personnel
Aptus Endosystems, aortic aneurysm

Rotation Medical Receives 510(k) Clearance for Implantable Collagen Scaffold Technology for Treating Rotator Cuff Disease

Tue, 04/01/2014 - 15:53
PLYMOUTH, Minn.--(Healthcare Sales & Marketing Network)--Rotation Medical, Inc., a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that it has received 510(k) clearance from the Food and Drug Adm...
Devices, Orthopaedic, FDA
Rotation Medical, collagen scaffold, rotator cuff

Elekta to demonstrate the synergy of technology and people at ESTRO 33

Tue, 04/01/2014 - 15:51
VIENNA, April 1, 2014 -- (Healthcare Sales & Marketing Network) -- ESTRO Booth #6200 – At ESTRO33, Elekta will demonstrate a comprehensive array of advanced solutions for cancer management. These products include the Versa HD™ treatment system, Monaco&reg...
Devices, Oncology
Elekta, Versa HD, brachytherapy, radiotherapy, treatment planning

Actavis Acquires Silom Medical Company

Tue, 04/01/2014 - 15:46
Establishes Leading Position in Fast-Growing Thai Pharmaceutical Market Immediately Accretive to Non-GAAP Earnings Enhances Actavis' Growth Platform in Southeast Asia DUBLIN, April 1, 2014 -- (Healthcare Sales & Marketing Network) -- Actavis plc ...
Biopharmaceuticals, Generics, Mergers & Acquisitions
Actavis, Silom Medical Company

Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer

Tue, 04/01/2014 - 15:44
SALT LAKE CITY, UT--(Healthcare Sales & Marketing Network) - Q Therapeutics, Inc. ("Q"), an emerging biotechnology company developing innovative cell therapy products for the treatment of neurodegenerative diseases, today announced that Mahendra ...
Regenerative Medicine, Neurology, Personnel
Q Therapeutics, Q-Cells, stem cell

Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer

Tue, 04/01/2014 - 15:42
WOODCLIFF LAKE, N.J., April 1, 2014 -- (Healthcare Sales & Marketing Network) -- Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer. In this capacity, Mr. Coughlin will be responsible for P...
Biopharmaceuticals, Generics, Personnel
Par Pharmaceutical

Cubist Appoints Robert J. Perez to Board of Directors

Tue, 04/01/2014 - 15:39
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Cubist (CBST) today announced the appointment of Robert J. Perez to its Board of Directors. Since 2012, Mr. Perez has served as Cubist’s President and Chief Operating Officer (COO). The Company also...
Biopharmaceuticals, Personnel
Cubist Pharmaceuticals

Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy

Tue, 04/01/2014 - 15:36
KING OF PRUSSIA, Pa.--(Healthcare Sales & Marketing Network)--Trevena, Inc. (TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the appointment of Rob...
Biopharmaceuticals, Personnel
Trevena, GPCR

Chimerix Appoints Lisa Ricciardi to Board of Directors

Tue, 04/01/2014 - 15:34
DURHAM, N.C., April 1, 2014 -- (Healthcare Sales & Marketing Network) -- Chimerix, Inc. (CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment of Lisa Ricciardi to the Comp...
Biopharmaceuticals, Personnel
Chimerix, Brincidofovir

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong